Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vandesande, Johan"'
Autor:
Engelen, Matthias M.1,2 (AUTHOR) matthias.engelen@uzleuven.be, Vandesande, Johan1 (AUTHOR), De Bent, Johan1 (AUTHOR), Van Laer, Christine2,3 (AUTHOR), Labarque, Veerle2,4 (AUTHOR), Jacquemin, Marc2,3 (AUTHOR), Peerlinck, Kathelijne1,2 (AUTHOR), Hermans, Cedric5 (AUTHOR), Verhamme, Peter1,2 (AUTHOR), Vanassche, Thomas1,2 (AUTHOR)
Publikováno v:
Haemophilia. Jul2023, Vol. 29 Issue 4, p1049-1055. 7p. 2 Charts, 3 Graphs.
Autor:
Engelen, Matthias M, Vandesande, Johan, De Bent, Johan, Van Laer, Christine, Labarque, Veerle, Jacquemin, Marc, Peerlinck, Kathelijne, Hermans, Cédric, Verhamme, Peter, Vanassche, Thomas
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia, p. [1-7] (2023)
BACKGROUND: Emicizumab is approved to prevent bleeding in patients with congenital haemophilia A with or without inhibitors. However, no randomized trials addressed the efficacy of emicizumab in acquired haemophilia A (AHA). AIMS: To report the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::80001bf61981dd1f5c95ad2d5c3f48f6
https://hdl.handle.net/2078.1/275605
https://hdl.handle.net/2078.1/275605
